The pyrolysis of cannabinoids

  • R. S. Tjeerdema
Part of the Reviews of Environmental Contamination and Toxicology book series (RECT, volume 99)

Abstract

Plants of the genus Cannabis are known to produce stronger and more immediate effects when smoked, the usual way of administration in Western countries, than when orally taken in similar amounts. In particular, the psychoactive effects are stronger than could be expected from the initial tetrahydrocannabinol (THC) content (Galanter et al. 1973). Therefore, it is important to investigate the products obtained following smoking instead of concentrating on the toxicology of the natural constituents.

Keywords

Nicotine Cocaine Pyran Butanol Lactone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrams RM, Davis KH, Jaeger MJ, Szeto HH (1985) Marijuana smoke production and delivery system. In: Harvey DJ, Paton WDM, Nahas GG (eds) Marihuana ‘84: proceedings of the Oxford Symposium on Cannabis. IRL Press, Oxford, England, p 205.Google Scholar
  2. Adams R, Cain CK, McPhee WD, Wearn RB (1941) Structure of cannabidiol. XII. Isomerization to tetrahydrocannabinols. J Am Chem Soc 63: 2209–2213.CrossRefGoogle Scholar
  3. Archer RA, Boyd DB, Demarco PV, Tyminski IJ, Allinger NL (1970) Structural studies of cannabinoids. A theoretical and proton magnetic resonance analysis. J Am Chem Soc 92: 5200–5206.PubMedCrossRefGoogle Scholar
  4. Bercht CAL, Samrah HM, Lousberg RJJCh, Theuns H, Salemink CA (1976) Isolation of vomifoliol and dihydrovomifoliol from Cannabis. Phytochemistry 15: 831–832.CrossRefGoogle Scholar
  5. Busch FW, Seid DA, Wei ET (1979) Mutagenic activity of marijuana smoke condensates. Cancer Lett 6: 319–324.PubMedCrossRefGoogle Scholar
  6. Chesher GB, Jackson DM, Starmer GA (1974) Interaction of Cannabis and general anesthetic agents in mice. Br J Pharmacol 50: 593–599.PubMedGoogle Scholar
  7. Elsohly MA, Elsohly HN, Turner CE (1983) Cannabis: new constituents and their pharmacological action. In: Breimer DD, Speiser P (eds) Topics in pharmaceutical sciences 1983. Elsevier Science Publishers BV, Amsterdam, p 429.Google Scholar
  8. Fairbairn JW, Liebmann JA, Rowan MG (1976) The stability of Cannabis and its preparations on storage. J Pharm Pharmacol 28: 1–7.PubMedCrossRefGoogle Scholar
  9. Fernandes M, Kluwe S, Coper H (1974) Cannabinoids and hexobarbital induced loss of righting reflexes. Nauyn Schmiedebergs Arch Pharmacol 283: 431–435.CrossRefGoogle Scholar
  10. Frizza J, Chesher GB, Jackson DM, Maolor R, Starmer GA (1977) The effect of Δ9tetrahydrocannabinol, cannabidiol, and cannabinol on the anaesthesia induced by various anaesthetic agents in mice. Psychopharmacology 55: 103–107.PubMedCrossRefGoogle Scholar
  11. Galanter M, Weingartner H, Vaughn FB, Roth WT, Wyatt RJ (1973) Δ9-trans-Tetrahydrocannabinol and natural marihuana. The controlled comparison. Arch Gen Psychiatry 28: 278–281.PubMedGoogle Scholar
  12. Gaoni Y, Mechoulam R (1964) Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 86: 1646–1647.CrossRefGoogle Scholar
  13. Gaoni Y, Mechoulam R (1966) Hashish VII. The isomerization of cannabidiol to tetrahydrocannabinols. Tetrahedron 22: 1481–1488.CrossRefGoogle Scholar
  14. Gaoni Y, Mechoulam R (1971) The isolation and structure of Δ9-tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 93: 217–224.PubMedCrossRefGoogle Scholar
  15. Hansteen RW, Miller RD, Lonero L, Reid LD, Jones B (1976) Effects of Cannabis and alcohol on automobile driving and psychomotor tracking. Ann NY Acad Sci 282: 240–256.PubMedCrossRefGoogle Scholar
  16. Hanus L, Krejci Z (1975) Isolation of two new cannabinoid acids from Cannabis sativa L of Czechoslovakian origin. Acta Univ Palacki Olomuc Fac Med 74: 161–165.Google Scholar
  17. Hattendorf CH, Hattendorf M, Coper H, Fernandes M (1977) Interaction between Δ9- tetrahydrocannabinol and d-amphetamine. Psychopharmacology 54: 177–182.PubMedCrossRefGoogle Scholar
  18. Hofmann D, Brunnemann KD, Gori GB, Wynder EL (1975) On the carcinogenicity of marijuana smoke. In: Runeckles VC (ed) Recent advances in phytochemistry. Plenum Press, New York, p 63.Google Scholar
  19. Hollister LE (1984) Health aspects in Cannabis use. In: Agurell S, Dewey WL, Willette RE (eds) Cannabinoids: chemical, pharmacologic, and therapeutic aspects. Academic Press, New York, p 3.Google Scholar
  20. Kephalas TA, Kiburis J, Michael CM, Miras CJ, Papadakis DP (1976) Some aspects of Cannabis smoke chemistry. In: Nahas GG (ed) Marijuana: chemistry, biochemistry, and cellular effects. Springer-Verlag, New York, p 39.Google Scholar
  21. Kettenes-van den Bosch JJ, Salemink CA (1977) Cannabis XVI. Constituents of marihuana smoke condensate. J Chromatogr 131: 422–424.PubMedCrossRefGoogle Scholar
  22. Kinzer GW, Foltz RL, Mitchell RI, Truitt EB (1974) The fate of the cannabinoid components of marijuana during smoking. Bull Narc 26: 41–54.Google Scholar
  23. Kubena RK, Barry H (1970) Interactions of Δ9-tetrahydrocannabinol with barbiturates and methamphetamine. J Pharmacol Exp Ther 173: 94–100.PubMedGoogle Scholar
  24. Kuppers FJEM, Bercht CAL, Salemink CA, Lousberg RJJCh, Terlouw JK, Heerma W (1975a) Cannabis XIV. Pyrolysis of cannabidiol. Analysis of the volatile constituents. J Chromatogr 108: 375–379.PubMedCrossRefGoogle Scholar
  25. Kuppers FJEM, Bercht CAL, Salemink CA, Lousberg RJJCh, Terlouw JK, Heerma W (1975b) Cannabis XV. Pyrolysis of cannabidiol. Structure elucidation of four pyrolytic products. Tetrahedron 31: 1513–1516.CrossRefGoogle Scholar
  26. Kuppers FJEM, Lousberg RJJCh, Bercht CAL, Salemink CA, Terlouw JK, Heerma W, Laven A (1973) Cannabis VIII. Pyrolysis of cannabidiol. Structure elucidation of the main pyrolytic product. Tetrahedron 29: 2797–2802.CrossRefGoogle Scholar
  27. Legator MS, Weber E, Connor T, Stoeckel M (1976) Failure to detect mutagenic effects of Δ9-tetrahydrocannabinol in the dominant lethal test, host-mediated assay, blood-urine studies, and cytogenic evaluation with mice. In: Braude MC, Szara S (eds) Pharmacology of marihuana. Raven Press, New York, p 699.Google Scholar
  28. Leuchtenberger C, Leuchtenberger R (1976) Cytological and cytochemical studies of the effect of fresh marijuana cigarette smoke on growth and DNA metabolism of animal and human lung cultures. In: Braude MC, Szara S (eds) Pharmacology of marihuana. Raven Press, New York, p 595.Google Scholar
  29. Leuchtenberger C, Leuchtenberger R, Chapuis L (1979) Difference in response to vitamin C between marihuana and tobacco smoke exposed human cell cultures. In: Nahas GG, Paton WDM (eds) Marihuana: biological effects. Pergamon Press, New York, p 209.Google Scholar
  30. Leuchtenberger C, Leuchtenberger R, Ritter U, Inui N (1973a) Effects of marijuana and tobacco smoke on DNA and chromosomal complement in human lung explants. Nature 242: 403–404.PubMedCrossRefGoogle Scholar
  31. Leuchtenberger C, Leuchtenberger R, Schneider A (1973b) Effects of marijuana and tobacco smoke on human physiology. Nature 241: 137–139.PubMedCrossRefGoogle Scholar
  32. Luteyn, JM, Spronck HJW, Salemink CA (1978) Cannabis XVIII. Isolation and synthesis of olivetol derivatives formed in the pyrolysis of cannabidiol. Red Tray Chim 97: 187–190.CrossRefGoogle Scholar
  33. Magus RD, Harris LS (1971) Carcinogenic potential of marihuana smoke condensate. Fed Proc 30: 279.Google Scholar
  34. Matsuyama SS, Jarvik LF, Fu T, Yen F (1976) Chromosome studies before and after supervised marijuana smoking. In: Braude MC, Szara S (eds) Pharmacology of marihuana. Raven Press, New York, p 723.Google Scholar
  35. Mechoulam R (1973) Cannabinoid chemistry. In: Mechoulam R (ed) Marijuana: chemistry, pharmacology, metabolism, and clinical effects. Academic Press, New York, p 2.Google Scholar
  36. Mechoulam R, Gaoni Y (1967) Recent advances in the chemistry of hashish. Fortsch Chem Org Naturst 25: 175–213.Google Scholar
  37. Mechoulam R, McCallum N, Levy S, Lander N (1976) Cannabinoid chemistry: an overview. In: Nahas GG (ed) Marijuana: chemistry, biochemistry, and cellular effects. Springer-Verlag, New York, p 3.Google Scholar
  38. Mechoulam R, Shvo Y (1963) Hashish I. The structure of cannabidiol. Tetrahedron 19: 2073–2078.CrossRefGoogle Scholar
  39. Mikes F, Waser G (1971) Marijuana components: effects of smoking on Δ9-tetrahydrocannabinol and cannabidiol. Science 172: 1158–1159.PubMedCrossRefGoogle Scholar
  40. Nahas GG (1984) Toxicology and pharmacology. In: Nahas GG (ed) Marihuana in science and medicine. Raven Press, New York, p 109.Google Scholar
  41. Nakahara Y, Sekine H (1985) Studies on confirmation of Cannabis use. I. Determination of the cannabinoid contents in marijuana cigarette, tar and ash using high performance liquid chromatography with electrochemical detection. J Anal Toxicol 9: 121–124.PubMedGoogle Scholar
  42. Nichols WW, Miller RC, Heneen W, Bradt C, Hollister L, Kanter S (1974) Cytogenetic studies on human subjects receiving marihuana and Δ9-tetrahydrocannabinol. Mutat Res 26: 413–417.PubMedCrossRefGoogle Scholar
  43. Novotny M, Lee ML, Bartle KD (1976) A possible chemical base for the higher mutagenicity of marijuana smoke as compared to tobacco smoke. Experientia 32: 280–282.PubMedCrossRefGoogle Scholar
  44. Novak J, Salemink CA (1984) Cannabis XXIX. Synthesis of four benzofuro-[6,7-c]-[2]benzopyrans related to cannabinol. J Chem Soc, Perkin Trans 1: 729–732.CrossRefGoogle Scholar
  45. Papadakis DP, Salemink CA, Alikaridis FJ, Kephalas TA (1983) Isolation and identification of new cannabinoids in Cannabis smoke. Tetrahedron 39: 2223–2225.CrossRefGoogle Scholar
  46. Phillips RN, Brown DJ, Forney RB (1971) Enhancement of depressant properties of alcohol or barbiturate in combination with aqueous suspended Δ9-tetrahydrocannabinol in rats. J Forensic Sci 16: 152–161.PubMedGoogle Scholar
  47. Pryor GT, Larsen FF, Husain S, Braude MC (1978) Interactions of Δ9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats. Pharmacol Biochem Behav 8: 295–318.PubMedCrossRefGoogle Scholar
  48. Quarles W, Ellman G, Jones R (1973) Toxicology of marijuana: conditions for conversion of cannabidiol to THC upon smoking. Clin Toxicol 6: 211–216.PubMedCrossRefGoogle Scholar
  49. Rosenkrantz H, Fleischman RW (1979) Effects of Cannabis on the lungs. In: Nahas GG, Paton WDM (eds) Marihuana: biological effects. Pergamon Press, New York, p 279.Google Scholar
  50. Salemink CA (1976) Pyrolysis of cannabinoids. In: Nahas GG (ed) Marijuana: chemistry, biochemistry, and cellular effects. Springer-Verlag, New York, p 31.Google Scholar
  51. Siemens AJ, Kalant H (1974) Metabolism of A’-tetrahydrocannabinol by rats tolerant to Cannabis. Can J Physiol Pharmacol 52: 1154–1166.PubMedCrossRefGoogle Scholar
  52. Siemens AJ, Khanna JM (1977) Acute metabolic interactions between ethanol and Cannabis. Alcoholism. Clin Exp Res 1: 343–348.CrossRefGoogle Scholar
  53. Sofia RD, Knobloch LC (1973) The interaction of Δ9-tetrahydrocannabinol pretreatment with various sedative-hypnotic drugs. Psychopharmacologia 30: 185–194.PubMedCrossRefGoogle Scholar
  54. Spronck HJW, Lousberg RJJCh (1977) Pyrolysis of cannabidiol. Structure elucidation of a major pyrolytic conversion product. Experientia 33: 705–706.PubMedCrossRefGoogle Scholar
  55. Spronck HJW, Salemink CA (1978) Cannabis XVII. Pyrolysis of cannabidiol. Structure elucidation of two pyrolytic conversion products. Red Tray Chim 97: 185–186.CrossRefGoogle Scholar
  56. Spronck HJW, Salemink CA, Alikaridis F, Papadakis D (1978) Pyrolysis of cannabinoids: a model experiment in the study of Cannabis smoking. Bull Narc 30: 55–59.PubMedGoogle Scholar
  57. Stoeckel M, Weber E, Connor T, Legator MS (1975) Failure to detect mutagenic effects of Δ9-tetrahydrocannabinol in in vitro and in vivo studies with mice. Mutat Res 31: 313–314.Google Scholar
  58. Turner CE, Elsohly MA (1979) Constituents of Cannabis sativa L. XVI. A possible decomposition pathway of Δ9-tetrahydrocannabinol to cannabinol. J Heterocyclic Chem 16: 1667–1668.CrossRefGoogle Scholar
  59. Turner CD, Elsohly MA, Boeren EG (1980) Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod 43: 169–234.PubMedCrossRefGoogle Scholar
  60. Turner CE, Hadley KW, Davis KH (1973a) Constituents of Cannabis sativa L. V. Stability of an analytical sample extracted with chloroform. Acta Pharm Jugoslav 23: 89–94.Google Scholar
  61. Turner CE, Hadley KW, Fetterman PS, Doorenbos NJ, Quimby MW, Waller C (1973b) Constituents of Cannabis sativa L. IV. Stability of cannabinoids in stored plant material. J Pharm Sci 62: 1601–1605.PubMedCrossRefGoogle Scholar
  62. van Went GF (1978) Mutagenicity testing of three hallucinogens: LSD, psilocybin, and Δ9-THC, using the micronucleus test. Experientia 34: 324–325.PubMedCrossRefGoogle Scholar
  63. Wehner FC, Van Rensburg Si, Thiel PG (1980) Mutagenicity of marijuana and transkei tobacco smoke condensates in the Salmonellalmicrosome assay. Mutat Res 77: 135–142.PubMedCrossRefGoogle Scholar
  64. Zimmerman AM, Stich H, San R (1978) Nonmutagenic action of cannabinoids in vitro. Pharmacology 16: 333–343.PubMedCrossRefGoogle Scholar
  65. Zimmerman AM, Zimmerman S, Raj A (1979) Effects of cannabinoids on spermatogenesis in mice. In: Nahas GG, Paton WDM (eds) Marihuana: biological effects. Perga-mon Press, New York, p 407.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1987

Authors and Affiliations

  • R. S. Tjeerdema
    • 1
  1. 1.Department of Environmental ToxicologyUniversity of CaliforniaDavisUSA

Personalised recommendations